Abstract

<h3>In Reply.—</h3> The comments by Drs Newbold and Tilkian underscore the fact that some aspects of vitamin B<sub>12</sub>metabolism in humans remain elusive despite 40 years of intensive study and thousands of publications.<sup>1</sup> Dr Newbold points out that the hereditary defects of vitamin B<sub>12</sub>metabolism are not addressed in our article. Since these disorders have been considered rare and since they are often detected in infancy or childhood, it seemed unlikely that the adults in our study population would have been affected. However, two reports<sup>2,3</sup>suggesting that these inborn errors of metabolism may not manifest themselves until adolescence or adulthood raise the possibility that the clinical spectrum of these disorders is broader than previously suspected and that the potential benefits of cyanocobalamin therapy have been underestimated in certain patient populations. We agree with Dr Tilkian that much can be learned from routine laboratory tests. We specifically

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.